» Articles » PMID: 27440971

Hypertension and Migraine in the Northern Manhattan Study

Overview
Journal Ethn Dis
Date 2016 Jul 22
PMID 27440971
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the association between migraine and hypertension in the Northern Manhattan Study (NOMAS), a multiethnic community-based sample.

Design: Cross-sectional cohort study.

Participants: 1338 NOMAS participants (mean age 68.1 ± 9.6 years, 37% male, 15% non-Hispanic White, 19% non-Hispanic Black, 67% Hispanic).

Setting: Northern Manhattan community.

Intervention: Participants were assessed for migraine symptoms using a self-report questionnaire based on criteria from the International Classification of Headache Disorders. Hypertension was defined as blood pressure ≥140/90 mm Hg, the patient's self-reported hypertension, or use of anti-hypertensive medications. Duration (≤9 years vs >9 years) and control (BP<140/90) of hypertension were examined. We estimated the association between hypertension and migraine (overall and with/without aura) using logistic regression, adjusting for sociodemographic and vascular risk factors.

Results: The majority of participants (80%) had no migraine, 6% had migraine with aura, and 15% had migraine without aura. Hypertension was present in 76% of the study population (7% had controlled hypertension ≤9 years duration, 5% controlled hypertension >9 years duration, 41% uncontrolled hypertension ≤9 years duration, 23% uncontrolled hypertension >9 years duration). Hypertension was associated with migraine (OR: 1.76, 95% CI: 1.21-2.54), both with and without aura. This association was particularly apparent for those with uncontrolled and long duration hypertension.

Conclusion: Hypertension, particularly uncontrolled and of long duration, is associated with migraine, both with and without aura, in a predominantly Hispanic community-based cohort.

Citing Articles

Arterial hypertension in the chronic evolution of migraine: bystander or risk factor? An overview.

Mazzacane F, Vaghi G, Ramusino M, Perini G, Costa A J Headache Pain. 2024; 25(1):13.

PMID: 38311745 PMC: 10840219. DOI: 10.1186/s10194-024-01720-7.


The prevalence of metabolic syndrome parameters and their association with headache characteristics among migraineurs.

Maghbooli M, Jameshorani M, Afshar S, Kamali K Curr J Neurol. 2023; 20(4):190-201.

PMID: 38011412 PMC: 9107570. DOI: 10.18502/cjn.v20i4.8344.


Prepregnancy Migraine, Migraine Phenotype, and Risk of Adverse Pregnancy Outcomes.

Purdue-Smithe A, Stuart J, Farland L, Kang J, Harriott A, Rich-Edwards J Neurology. 2023; 100(14):e1464-e1473.

PMID: 36657989 PMC: 10104618. DOI: 10.1212/WNL.0000000000206831.


Stroke-prone salt-sensitive spontaneously hypertensive rats show higher susceptibility to spreading depolarization (SD) and altered hemodynamic responses to SD.

Kang E, Prager O, Lublinsky S, Oliveira-Ferreira A, Reiffurth C, Major S J Cereb Blood Flow Metab. 2022; 43(2):210-230.

PMID: 36329390 PMC: 9903222. DOI: 10.1177/0271678X221135085.


Mechanotransduction: Exploring New Therapeutic Avenues in Central Nervous System Pathology.

Rocha D, Carvalho E, Relvas J, Oliveira M, Pego A Front Neurosci. 2022; 16:861613.

PMID: 35573316 PMC: 9096357. DOI: 10.3389/fnins.2022.861613.


References
1.
Fagernaes C, Heuch I, Zwart J, Winsvold B, Linde M, Hagen K . Blood pressure as a risk factor for headache and migraine: a prospective population-based study. Eur J Neurol. 2014; 22(1):156-62, e10-1. DOI: 10.1111/ene.12547. View

2.
Loder S, Sheikh H, Loder E . The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey studies. Headache. 2015; 55(2):214-28. DOI: 10.1111/head.12506. View

3.
Schuh-Hofer S, Flach U, Meisel A, Israel H, Reuter U, Arnold G . Efficacy of lisinopril in migraine prophylaxis--an open label study. Eur J Neurol. 2007; 14(6):701-3. DOI: 10.1111/j.1468-1331.2007.01764.x. View

4.
Voss J, Scher A . Headache linked with incidence of metabolic syndrome: comment on migraine, headache and development of metabolic syndrome: an 11-year follow-up in the HUNT study. Pain. 2013; 154(8):1163-1164. DOI: 10.1016/j.pain.2013.05.013. View

5.
Monteith T, Gardener H, Rundek T, Dong C, Yoshita M, Elkind M . Migraine, white matter hyperintensities, and subclinical brain infarction in a diverse community: the northern Manhattan study. Stroke. 2014; 45(6):1830-2. PMC: 4049191. DOI: 10.1161/STROKEAHA.114.005447. View